Medical and radiation oncology for breast cancer in developing countries with particular reference to locally advanced breast cancer

World Journal of Surgery

Volumn 27, Issue 8, 2003, Pages 924-927

  Murray, Elizabeth M ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; PROGESTERONE RECEPTOR; TAMOXIFEN; TAXANE DERIVATIVE;

BREAST CANCER; BREAST DISEASE; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CLINICAL PROTOCOL; DEVELOPING COUNTRY; FEMALE; HUMAN; ONCOLOGY; PREOPERATIVE TREATMENT; REVIEW; WORLD HEALTH ORGANIZATION;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; CULTURE; DEVELOPING COUNTRIES; FEMALE; HUMANS; RADIOTHERAPY, ADJUVANT; SOUTH AFRICA; TAMOXIFEN;

EID: 0041324742     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-003-6977-9     Document Type: Review

References (34)

1. Forbes JF. The incidence of breast cancer: the global burden. Public health considerations. Semin. Oncol. 1997;24:S1-S35
2. Editorial. A manipulated dichotomy in global health policy. Lancet 2000;355:1923
3. Abebe E, Ben Ayed F, Gad El Mawla N, et al. Editorial. The fight against cancer in countries with limited resources: the Djerba statement, August 9, 1995. Ann. Oncol. 1995;6:965-966
4. Cavalli F. Editorial: The Djerba statement: just another declaration, or a new beginning? Ann. Oncol. 1995;6:963-964
5. Porter A, Aref A, Chodounsky Z, et al. A global strategy for radiotherapy: a WHO consultation. Clin. Oncol. 1999;11:368-370
6. Jones SB. Cancer in the developing world: a call to action. B.M.J. 1999;319:505-508
7. Sikora K. Developing a global strategy for cancer. Eur. J. Cancer 1999;35:24-31
8. Wright SV. An investigation into the causes of absconding among black African breast cancer patients. S. Afr. Med. J. 1997;87:1540-1543
9. Stjernswôrd J, Stanley K, Henderson IC. Cancer control: introduction to a series of reports on strategies and approaches. Bull. W.H.O. 1986;64:69-71
10. Koroltchouk V, Stanley K, Stjernswôrd J. The control of breast cancer: a World Health Organization perspective. Cancer 1990;65:2803-2810
11. Hortobagyi GN, Singletary SE, Strom EA. Treatment of locally advanced and inflammatory breast cancer. In Harris JR, Lippman ME, Morrow M, editors, Diseases of the Breast, 2nd edition, Philadelphia, Lippincott, Williams & Wilkins, 2000;645-660
12. Cavalli F. What should we do with cancer in developing countries? World Health Organization Programme on Cancer Control Abstract 9810, 1998
13. Murray EM, Gudgeon A. Screening for breast cancer in South Africa. S. Afr. Med. J. 1994;84:116
14. Pinotti JA, Barros ACSD, Hegg R, et al. Breast cancer control programme in developing countries. Eur. J. Gynaecol. Oncol. 1993;14:355-362
15. Hortobagyi GN. Multi-disciplinary management of advanced primary and metastatic breast cancer. Cancer 1994;74:416-423
16. Perez CA, Fields JN, Fracasso PM, et al. Management of locally advanced carcinoma of the breast II. Cancer 1994;74:466-475
17. Goldhirsch A, Coats AS, Colleoni M, et al. Adjuvant chemoendocrine therapy in postmenopausal breast cancer: cyclophosphamide, methotrexate, and fluorouracil dose and schedule may make a difference. J. Clin. Oncol. 1998;16:1358-1362
18. Engelsman E, Klijn JCM, Rubens RD, et al. "Classical" CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer. Eur. J. Cancer 1991;27:996-970
19. Mauriac L, MacGrogan G, Avril A, et al. Primary chemotherapy: the European experience. In Dowsett M, Howell A, editors, Scientific updates, 4, Primary Medical Therapy for Breast Cancer: Clinical and Biological Aspects, Amsterdam, Elsevier, 1999;11-21
20. Bonadonna G, Valagussa P, Brambilla C, et al. Primary chemotherapy in operable breast cancer: 8 year experience at the Milan Cancer Institute. J. Clin. Oncol. 1998;16:93-100
21. Piccart MJ, Lohrisch C, Di Leo A. Best type of adjuvant chemotherapy. The Breast 2001;10:S8
22. Clark J, Rosenman J, Cance W, et al. Extending the indications for breast-conserving treatment to patients with locally advanced breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 1998;42:345-350
23. EORTC Breast Cancer Co-operative Group. Adjuvant systemic therapy. In Blichert-Toft M, editor, Manual for Clinical Research and Treatment in Breast Cancer Almere, The Netherlands, Excerpta Medica, 2000;92-95
24. Pritchard KI. Best types of endocrine treatments. The Breast 2001;10: S9
25. Abrams JS. A review of the National Institutes of Health [NIH] Consensus Development Conference on Adjuvant Therapy of Breast Cancer. The Breast 2001;10:S10-S11
26. Howell A, Dowsett M. Primary medical therapy: current status and questions which need to be answered. In Dowsett M, Howell A, editors, Scientific Updates, 4, Primary Medical Therapy for Breast Cancer: Clinical and Biological Aspects Amsterdam, Elsevier, 1999;127-130
27. Early Breast Cancer Trialist Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomized trials. Lancet 2000;355:1757-1770
28. Harris JR, Halpin-Murphy P, McNeese M, et al. Consensus statement in postmastectomy radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 1999;44:989-990
29. Recht A, Edge SB, Solin LJ, et al. Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology. J. Clin. Oncol. 2001;19:1539-1569
30. Whelan TJ, MacKenzie RG, Levine M et al. A randomized trial comparing two fractionation schedules for breast irradiation postlumpectomy in node-negative breast cancer (Abstract). Program/Proceedings of the American Society of Clinical Oncology Thirty-Sixth Annual Meeting. J. Clin. Oncol. 2000;19:2a
31. Fairchild AM, Weir LM, Olivotto IA. Loco-regional radiation for high risk breast cancer - results of short fractionation. Breast Cancer Res. Treat. 2000;64:35
32. Yarnold J. Radiation in the context of multidisciplinary approaches: locally advanced disease. The Breast 2000;10:S8
33. Arriagada R, Mouriesse H, Sarazin D, et al. Radiotherapy alone in breast cancer. 1. Analysis of tumour parameters, tumour dose and local control: the experience of the Gustave-Roussy Institute and the Princess Margaret Hospital. Int. J. Radiat. Oncol. Biol. Phys. 1985;11:1751-1757
34. Tognoni G. North-south asymmetry. Ann. Oncol. 1993;4:7-8